Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer

joshua.meeks@northwestern.edu

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001007998	ATACseq FASTq files from RT4 cells treated with KDM5i C70	Illumina HiSeq 4000	4
EGAD00001007999	RNAseq FASTq files from RT4 cells treated with FGFRi Erdafitinib	Illumina NovaSeq 6000	6
EGAD00001008000	RNAseq FASTq files from RT4 cells treated with KDM5i C70	Illumina NovaSeq 6000	6
EGAD00001008001	single-cell RNAseq FASTq files for three muscle-invasive bladder tumors	Illumina HiSeq 2500	12
EGAD00001008002	RNAseq FASTq files from 31 post-treatment tumors from PURE01	Illumina HiSeq 2500	31
EGAD00001008003	RNAseq FASTq files from 82 pre-treatment tumors from PURE01	Illumina HiSeq 4000	82